Clinical trials recruiting for Interstitial Lung Disease
31
Recruiting trials
34
US states with sites
32
Countries
19%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| New York | 6 |
| Florida | 5 |
| Oregon | 5 |
| California | 4 |
| Colorado | 4 |
| Kansas | 4 |
| North Carolina | 4 |
| Pennsylvania | 4 |
| Kentucky | 3 |
| Michigan | 3 |
| Ohio | 3 |
| Arizona | 2 |
Top cities
Bend, Oregon 5Kansas City, Kansas 4New York, New York 4Aurora, Colorado 3Cincinnati, Ohio 3Durham, North Carolina 3Los Angeles, California 3Louisville, Kentucky 3Naples, Florida 3Philadelphia, Pennsylvania 3
Self-screener
Recruiting trials
- 129Xe MRI Cardiopulmonary
- A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
- A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease
- An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
- Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
- DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
- Effect of HIgh-flow Therapy in Long-term Oxygen Therapy
- Effects of Oxygen Supplementation During the 6-Minute Walk Test in Chronic Respiratory Failure or Exertional Hypoxemia
- Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease
- Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Exploration of Metabolome in Patients With Interstitial Lung Disease and Pulmonary Hypertension With or Without Specific Pulmonary Hypertension Treatment
- Feasibility of Semaglutide in Advanced Lung Disease
- Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging
- Generative AI Impact on Rheumatoid Arthritis Complications Diagnosis
- Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
- ILD-SARDs Registry and Biorepository
- Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath
- Practice of Oxygenation and Respiratory Support During Fiberoptic Bronchoscopy
- Pulmonary Hypertension SOLAR
- Reducing Chronic Breathlessness in Adults by Following a Self-guided, Internet Based Supportive Intervention (SELF-BREATHE)
- Reducing Respiratory Symptoms of Pulmonary Irradiation in Interstitial Lung Disease
- Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease
- Screening of Patients With Rheumatoid Arthritis for Interstitial Lung Disease
- Taiwan Interstitial Lung Disease Multi-center Investigation and Registry
- The Benefits of Home Exercise in Pulmonary Hypertension Interstitial Lung Disease
- The Effect of Exercise Training on lncRNA Expression in Rheumatoid Arthritis
- Titrated Ambulatory Oxygen in Fibrotic ILD and COPD With Isolated Exertional Hypoxemia
- Ultrasound and Respiratory Physiological Signals in Lung Diseases
- dEtection of rheumAtoid aRthritis - Interstitial Lung dIseasE by Thoracic ultRasound
Related conditions
Trials recruiting for Interstitial Lung Disease often also study these conditions. Each links to its own recruiting-trial list.
Hypertension 1201Pulmonary hypertension 95COPD 444Rheumatoid arthritis 314Lung cancer 2180Pulmonary arterial hypertension 49Cardiovascular Diseases 164Asthma 382Systemic Sclerosis 27Systemic lupus erythematosus 119
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Interstitial Lung Disease trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.